Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

March 12, 2007

New York, March 12, 2007 – After fleeing persecution in Myanmar and living in appalling conditions for many years in Bangladesh, hundreds of refugee families are now requested by the Bangladeshi authorities to evacuate and leave without being provided with an alternative place to go, the medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

March 08, 2007

Mopeia/Geneva, March 8, 2007 – An estimated 136,000 people have been displaced in Mozambique due to floods that affected the provinces surrounding the Zambezi river at the end of January 2007. Despite optimism over the initial aid response, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) expresses concern over the health situation of flood victims in Zambezia Province. MSF calls on the Mozambican government and humanitarian aid groups to urgently step up their interventions to ensure that food and non-food relief supplies reach the thousands of families affected by the floods.

March 05, 2007

New York/Geneva, March 5, 2007 — On the day of the last hearing in Swiss pharmaceutical company Novartis legal challenge against India's Patents Act, the company continues to ignore the global protests asking it to drop the case. The international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) strongly condemns Novartis for pushing forward with the case and is asking the company's shareholders to urge CEO Vasella to withdraw the legal challenge in India, which could jeopardize worldwide access to essential medicines.

March 02, 2007

New York/Berlin, March 3, 2007 — As the international humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) continues to provide medical care, drinking water, and relief goods to over 60,000 displaced persons in southeastern Chad, it urges other aid agencies to do more.

March 01, 2007

Paris/New York, March 1, 2007 — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the introduction of a new user-friendly and cheaper 2-in-1 tablet of artesunate-amodiaquine against malaria. The treatment, also called ASAQ, is the result of research by the non-profit Drugs for Neglected Diseases initiative (DNDi) in cooperation with sanofi-aventis and it demonstrates how research and development can take place without patenting for availability in the public domain.

March 01, 2007

Los Angeles, March 1, 2007 — New data released by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the 14th Conference on Retroviruses and Opportunistic Infections (CROI) in Los Angeles this week demonstrates good clinical outcomes for second-line antiretroviral therapy (ART) in resource-poor settings. Newer medicines needed for second-line regimens, however, remain unaffordable and largely unavailable in affected countries, and adapted diagnostic tools needed to appropriately monitor lifelong treatment are missing.

February 13, 2007

New York/Conakry, February 13, 2007 – Since Saturday, February 10, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has treated approximately 355 people injured during demonstrations and fighting in Conakry and Gueckedou, Guinea. The majority of them were wounded by stray bullets.

January 29, 2007

New York, January 29, 2007 – Since late December 2006, new attacks in west Darfur, Sudan, have destroyed several villages and have led to the displacement of thousands of people. Displaced persons have found refuge in Ardamata and Dorti camps, situated on the outskirts of El Geneina, the capital of west Darfur, while other people remain blocked further north in Tanjeke.

January 29, 2007

New Delhi/Geneva, 29 January 2007 – As pharmaceutical company Novartis proceeded with its legal challenge against the Indian government in a court hearing in Chennai, India, today, nearly a quarter of a million people from over 150 countries expressed their concern about the negative impact the company's actions could have on access to medicines in developing countries. The Indian Network for People with HIV/AIDS (INP+), the People's Health Movement, the Centre for Trade and Development (Centad), together with the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF), called on the company again today to immediately cease its legal action in India.

January 12, 2007

New York, January 12, 2007— Proposals to accelerate the development of tuberculosis (TB) drugs were outlined today at the conclusion of a two-day symposium titled "No Time to Wait," convened in New York this week by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontires (MSF) with the support of Howard P. Milstein and Weill Cornell Medical College's Abby and Howard P. Milstein Program in Chemical Biology. The symposium brought together more than 100 TB specialists, drug developers and regulators, policy makers, donors and activists to outline practical proposals to fill the gaps in TB drug research and development (R&D).

Pages